Alkermes (ALKS) Short-term Investments (2011 - 2026)
Alkermes (ALKS) posted quarterly Short-term Investments of $145.0 million for Q2 2026, down 70.67% year-over-year from $494.5 million in Q2 2025, and down 9.52% quarter-over-quarter from $160.3 million in Q1 2026.
Alkermes (ALKS) Short-term Investments (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Short-term Investments for 16 consecutive years, with $145.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Short-term Investments fell 70.67% year-over-year to $145.0 million; the TTM figure through Jun 2026 stood at $145.0 million (down 70.67% YoY), while the FY2025 annual figure was $731.2 million, up 58.78% from the prior year.
- Short-term Investments declined to $145.0 million in Q2 2026 per ALKS's latest filing, from $160.3 million in the prior quarter.
- Across five years, Short-term Investments topped out at $731.2 million in Q4 2025 and bottomed at $145.0 million in Q2 2026.
- Historically, Short-term Investments has averaged $352.9 million across 5 years, with a median of $320.3 million in 2022.
- Annual changes were most pronounced in 2024 — Short-term Investments soared 112.3% — and 2026, when it slumped 70.67%.
- Alkermes' Short-term Investments stood at $316.0 million in 2022, then increased by 0.01% to $316.0 million in 2023, then soared by 45.72% to $460.5 million in 2024, then soared by 58.78% to $731.2 million in 2025, then sank by 80.16% to $145.0 million in 2026.
- Business Quant data shows ALKS's Short-term Investments at $145.0 million in Q2 2026, $160.3 million in Q1 2026, and $731.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.05 Mn |
| Mar 31, 2026 | 160.31 Mn |
| Dec 31, 2025 | 731.21 Mn |
| Sep 30, 2025 | 494.67 Mn |
| Jun 30, 2025 | 494.54 Mn |
| Mar 31, 2025 | 484.21 Mn |
| Dec 31, 2024 | 460.52 Mn |
| Sep 30, 2024 | 512.57 Mn |
| Jun 30, 2024 | 340.97 Mn |
| Mar 31, 2024 | 324.30 Mn |
| Dec 31, 2023 | 316.02 Mn |
| Sep 30, 2023 | 241.44 Mn |
| Jun 30, 2023 | 163.25 Mn |
| Mar 31, 2023 | 279.06 Mn |
| Dec 31, 2022 | 315.99 Mn |
| Sep 30, 2022 | 316.23 Mn |
| Jun 30, 2022 | 326.32 Mn |
| Mar 31, 2022 | 246.32 Mn |
| Dec 31, 2021 | 198.77 Mn |
| Sep 30, 2021 | 249.86 Mn |